Roda, Giulia
(2013)
Sviluppo di nuovi approcci terapeutici nelle Malattie Infiammatorie dell'intestino:cibi funzionali e nutraceutci vs vaccini a base di peptidi sintetici, [Dissertation thesis], Alma Mater Studiorum Università di Bologna.
Dottorato di ricerca in
Scienze degli alimenti, nutrizione animale e sicurezza alimentare, 25 Ciclo. DOI 10.6092/unibo/amsdottorato/5362.
Documenti full-text disponibili:
Abstract
Inflammatory Bowel Diseases (IBD) are intestinal chronic relapsing diseases which ethiopathogenesis remains uncertain. Several group have attempted to study the role of factors involved such as genetic susceptibility, environmental factors such as smoke, diet, sex, immunological factors as well as the microbioma. None of the treatments available satisfy several criteria at the same time such as safety, long-term remission, histopatological healing, and specificity.
We used two different approaches for the development of new therapeutic treatment for Inflammatory Bowel Disease.
The first is focused on the understanding of the potential role of functional food and nutraceuticals nutrients in the treatment of IBD. To do so, we investigated the role of Curcuma longa in the treatment of chemical induced colitis in mice model. Since Curcma Longa has been investigated for its antinflammatory role related to the TNFα pathway as well investigators have reported few cases of patients with ulcerative colites treated with this herbs, we harbored the hypothesis of a role of Curcuma Longa in the treatment f IBD as well as we decided to assess its role in intestinal motility.
The second part is based on an immunological approach to develop new drugs to induce suppression in Crohn’s disease or to induce mucosa immunity such as in colonrectal tumor. The main idea behind this approach is that we could manipulate relevant cell-cell interactions using synthetic peptides. We demonstrated the role of the unique interaction between molecules expressed on intestinal epithelial cells such as CD1d and CEACAM5 and on CD8+ T cells. In normal condition this interaction has a role for the expansion of the suppressor CD8+ T cells. Here, we characterized this interaction, we defined which are the epitope involved in the binding and we attempted to develop synthetic peptides from the N domain of CEACAM5 in order to manipulate it.
Abstract
Inflammatory Bowel Diseases (IBD) are intestinal chronic relapsing diseases which ethiopathogenesis remains uncertain. Several group have attempted to study the role of factors involved such as genetic susceptibility, environmental factors such as smoke, diet, sex, immunological factors as well as the microbioma. None of the treatments available satisfy several criteria at the same time such as safety, long-term remission, histopatological healing, and specificity.
We used two different approaches for the development of new therapeutic treatment for Inflammatory Bowel Disease.
The first is focused on the understanding of the potential role of functional food and nutraceuticals nutrients in the treatment of IBD. To do so, we investigated the role of Curcuma longa in the treatment of chemical induced colitis in mice model. Since Curcma Longa has been investigated for its antinflammatory role related to the TNFα pathway as well investigators have reported few cases of patients with ulcerative colites treated with this herbs, we harbored the hypothesis of a role of Curcuma Longa in the treatment f IBD as well as we decided to assess its role in intestinal motility.
The second part is based on an immunological approach to develop new drugs to induce suppression in Crohn’s disease or to induce mucosa immunity such as in colonrectal tumor. The main idea behind this approach is that we could manipulate relevant cell-cell interactions using synthetic peptides. We demonstrated the role of the unique interaction between molecules expressed on intestinal epithelial cells such as CD1d and CEACAM5 and on CD8+ T cells. In normal condition this interaction has a role for the expansion of the suppressor CD8+ T cells. Here, we characterized this interaction, we defined which are the epitope involved in the binding and we attempted to develop synthetic peptides from the N domain of CEACAM5 in order to manipulate it.
Tipologia del documento
Tesi di dottorato
Autore
Roda, Giulia
Supervisore
Dottorato di ricerca
Scuola di dottorato
Scienze veterinarie
Ciclo
25
Coordinatore
Settore disciplinare
Settore concorsuale
URN:NBN
DOI
10.6092/unibo/amsdottorato/5362
Data di discussione
19 Aprile 2013
URI
Altri metadati
Tipologia del documento
Tesi di dottorato
Autore
Roda, Giulia
Supervisore
Dottorato di ricerca
Scuola di dottorato
Scienze veterinarie
Ciclo
25
Coordinatore
Settore disciplinare
Settore concorsuale
URN:NBN
DOI
10.6092/unibo/amsdottorato/5362
Data di discussione
19 Aprile 2013
URI
Statistica sui download
Gestione del documento: